...
首页> 外文期刊>International journal of gynecological cancer: official journal of the International Gynecological Cancer Society >Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers.
【24h】

Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers.

机译:恶性混合苗勒氏瘤与高级别子宫内膜样,透明细胞和乳头状浆液性子宫内膜癌患者的生存结局比较。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Malignant mixed mullerian tumors (MMMTs) are an aggressive subtype of endometrial cancer (EC). Previous studies compare survival between high-grade endometrioid (EM), clear cell (CC), and papillary serous (PS) ECs; yet few studies compare MMMTs to these aggressive subtypes. The goal of this study was to compare recurrence-free survival (RFS), disease-specific survival (DSS), and overall survival (OS) among EC subtypes. METHODS: We conducted a retrospective cohort study of EC cases treated at Magee-Women's Hospital between 1996 and 2008. Kaplan-Meier estimates of RFS, DSS, and OS as well as and log-rank tests were used to compare survival distributions between histologic subtypes. Cox regression was used to estimate hazard ratios for histologic subtypes, adjusted for other significant prognostic factors. Interactions between histologic subtype and prognostic factors were examined to assess effect modification. RESULTS: This cohort included 81 MMMT (15%), 254 high-grade EM (46%), 73 CC (13%), and 147 PS (26%) cases. Compared to high-grade EM (6%) and CC (7%) cases, relatively more MMMT (12%) and PS (12%) cases were nonwhite. Stage differed significantly among the subtypes, with 36%, 34%, 37%, and 51% of MMMT, high-grade EM, CC, and PS cases, respectively, diagnosed at advanced late stage (P<0.001). Kaplan-Meier curves and log-rank tests showed similar RFS, DSS, and OS between MMMT, high-grade EM, CC, and PS cases stratified by stage. In adjusted Cox regression models, RFS and DSS were not significantly different between MMMT and other subtypes. High-grade EM cases had a significantly better OS compared to MMMT cases (HR, 0.63; 95% confidence interval [CI], 0.41-0.98). CONCLUSIONS: This is the first retrospective study to suggest that certain survival outcomes are similar among MMMT, high-grade EM, CC, and PS subtypes. Other large-scale studies are needed to confirm these findings.
机译:简介:恶性混合苗勒氏瘤(MMMT)是子宫内膜癌(EC)的一种侵略性亚型。先前的研究比较了高级子宫内膜样(EM),透明细胞(CC)和乳头浆液性(PS)EC的存活率。很少有研究将MMMT与这些侵略性亚型进行比较。这项研究的目的是比较EC亚型之间的无复发生存期(RFS),疾病特异性生存期(DSS)和总体生存期(OS)。方法:我们进行了一项回顾性队列研究,研究对象是1996年至2008年在Magee-Women's医院治疗的EC病例。使用Kaplan-Meier对RFS,DSS和OS的估计以及对数秩检验来比较组织学亚型之间的生存分布。使用Cox回归来估计组织学亚型的危险比,并针对其他重要的预后因素进行调整。检查组织学亚型和预后因素之间的相互作用,以评估疗效的改变。结果:该队列包括81例MMMT(15%),254例高级EM(46%),73例CC(13%)和147例PS(26%)。与高级EM(6%)和CC(7%)病例相比,非白人的MMMT(12%)和PS(12%)病例相对较多。亚型之间的分期显着不同,分别在晚期晚期被诊断出的MMMT,高级EM,CC和PS病例分别为36%,34%,37%和51%(P <0.001)。 Kaplan-Meier曲线和对数秩检验显示,MMMT,高级EM,CC和PS案例按阶段分层之间具有相似的RFS,DSS和OS。在调整后的Cox回归模型中,MMMT与其他亚型之间的RFS和DSS没有显着差异。与MMMT案例相比,高等级EM案例的OS明显更好(HR,0.63; 95%置信区间[CI],0.41-0.98)。结论:这是第一项回顾性研究,表明MMMT,高级EM,CC和PS亚型的某些生存结果相似。需要其他大规模研究来证实这些发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号